Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen<i> (Salvia miltiorrhiza)</i>

<div>Rosmarinic acid inhibited the catalytic activity of ERp57. Effects of rosmarinic acid and daucosterol at 3, 10, 30, 100, and 300 <i>μ</i>M on ERp57 activity, as determined by insulin reduction assay. Rosmarinic acid, but not daucosterol, inhibited the activity of ERp57 in a concentration-dependent manner.</div>

Evidence-Based Complementary and Alternative Medicine

fig5

Figure 5

Figure 5: Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen<i> (Salvia miltiorrhiza)</i> 

Evidence-Based Complementary and Alternative Medicine

Discovery of a Novel ERp57 Inhibitor as Antiplatelet Agent from Danshen (Salvia miltiorrhiza)

Figure 5